316 growth-stage healthtech investors
We list 316 growth-stage healthtech investors as of November 2026: 121 have an SEC filing on file and 195 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (30), New York (21) and Massachusetts (12).
Top 5 growth-stage healthtech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Bullhound Capital
Type: VC firm · HQ: London, United Kingdom · Stages: Growth · Focus: Healthtech, AI, Quantum, Robotics · Latest activity: New deal, Oct 2026 · Fund size or assets: €1.0B (own site)
Dated new deal in Oct 2026; €1.0B on file (own site); states healthtech and digital health as a focus; backs growth-stage; 8 named decision-makers on file.
Transformation Capital
Type: VC firm · HQ: Boston, MA · Stages: Growth · Focus: Healthtech, Medtech · Latest activity: New fund, Sep 2026 · Fund size on file: $800M (SEC Form D, 2022)
Latest fund filing dated Sep 2026; $800M fund on file (SEC Form D, 2022); states healthtech and digital health as a focus; backs growth-stage; 8 named decision-makers on file.
MS+PARTNERS
Type: Fund manager · HQ: London, United Kingdom · Stages: Growth · Focus: Healthtech, Industrial Tech, Energy, Climate Tech · Latest activity: New fund, Sep 2026 · Fund size or assets: €300M (own site)
Latest fund filing dated Sep 2026; €300M on file (own site); states healthtech and digital health as a focus; backs growth-stage; 6 named decision-makers on file.
Echo Health Ventures
Type: Corporate VC · HQ: Durham, NC · Stages: Growth · Focus: Healthtech, Medtech · Latest activity: Portfolio news, Sep 2026 · Private fund assets: $518M (SEC Form ADV)
Portfolio news dated Sep 2026; $518M on file (SEC Form ADV); states healthtech and digital health as a focus; backs growth-stage; 2 named decision-makers on file.
NewVale Capital
Type: VC firm · HQ: Boulder, CO · Stages: Growth · Focus: Healthtech, Biotech, Medtech · Latest activity: New fund, Oct 2026 · Fund size on file: $250M (SEC Form D, 2026)
Latest fund filing dated Oct 2026; $250M fund on file (SEC Form D, 2026); states healthtech and digital health as a focus; backs growth-stage; 8 named decision-makers on file.
First 25 of 316 growth-stage healthtech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Bullhound Capital | VC firm | London, United Kingdom | Growth | Healthtech, AI, Quantum, Robotics | New deal, Oct 2026 | €1.0B (own site) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Transformation Capital | VC firm | Boston, MA | Growth | Healthtech, Medtech | New fund, Sep 2026 | $800M (SEC Form D, 2022) | 4 Nov 2026 | 8 names, firm email · Unlock |
| MS+PARTNERS | Fund manager | London, United Kingdom | Growth | Healthtech, Industrial Tech, Energy, Climate Tech | New fund, Sep 2026 | €300M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| Echo Health Ventures | Corporate VC | Durham, NC | Growth | Healthtech, Medtech | Portfolio news, Sep 2026 | $518M (SEC Form ADV) | 5 Nov 2026 | 2 names · Unlock |
| NewVale Capital | VC firm | Boulder, CO | Growth | Healthtech, Biotech, Medtech | New fund, Oct 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Town Hall Ventures | VC firm | New York, NY | Growth | Healthtech, Impact, Medtech | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 5 Nov 2026 | 8 names · Unlock |
| Quartus | VC firm | New York, NY | Growth | Healthtech, AI, B2B, Edtech | New fund, Sep 2026 | $150M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Audere | VC firm | Austin, TX | Growth | Healthtech, Cybersecurity, AI, Robotics | New fund, Oct 2026 | $100M (SEC Form D, 2024) | 4 Nov 2026 | 8 names, firm email · Unlock |
| JSTAR Capital | VC firm | Austin, TX | Growth | Healthtech, AI, Fintech, Medtech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| HLM Investment Partners | VC firm | Waltham, MA | Growth | Healthtech, Medtech | New fund, Aug 2026 | $61M (SEC Form D, 2025) | 4 Nov 2026 | 4 names · Unlock |
| Lauxera Capital Partners | VC firm | Paris, France | Growth | Healthtech, Medtech | New fund, May 2026 | €800M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Healthtech, Biotech, Medtech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Highland Europe | VC firm | London, United Kingdom | Growth | Healthtech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| FTV Capital | VC firm | San Francisco, CA | Growth | Healthtech, Fintech, SaaS, B2B | New fund, Jul 2026 | $11.9B (SEC Form ADV) | 5 Nov 2026 | 8 names · Unlock |
| Gresham House Ventures | VC firm | London, United Kingdom | Series A, Growth | Healthtech, AI, Marketing Tech, Fintech | New deal, Sep 2026 | £200M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Healthtech, Biotech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Salica Investments | Fund manager | London, United Kingdom | Seed, Series A, Growth | Healthtech, Fintech, AI, Climate Tech | Portfolio news, Oct 2026 | £760M (own site) | 4 Nov 2026 | 8 names · Unlock |
| PXN Ventures | Fund manager | Manchester, United Kingdom | Pre-seed, Seed, Series A, Growth | Healthtech, Generalist, SaaS, Deep Tech | Portfolio news, Nov 2026 | £760M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Longitude Venture Partners | VC firm | Menlo Park, CA | Growth | Healthtech, Biotech, Medtech | New deal, Jun 2026 | $600M (SEC Form D, 2022) | 5 Nov 2026 | 8 names · Unlock |
| Alpha Partners | VC firm | New York, NY | Series B, Growth | Healthtech, AI, Developer Tools, Cybersecurity | New fund, Oct 2026 | $200M (SEC Form D, 2024) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Healthtech, Future of Work, AI, SaaS | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| The FSE Group | Fund manager | Fleet, United Kingdom | Seed, Series A, Growth | Healthtech, Generalist, Climate Tech, SaaS | Portfolio news, Sep 2026 | £395M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Healthtech, Biotech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Edtech, Developer Tools, Mobility | Portfolio news, Oct 2026 | £3.0B (own site) | 4 Nov 2026 | 8 names · Unlock |
You are seeing 25 of 316. The full list adds 291 more investors and 1,525 named decision-makers.
This list is over 300 rows, so it is delivered inside Global Bundle. One-time payment. No subscription. No account.
Or get the free sample.
Need fewer rows than the whole file? The investor matching tool, opened here for healthtech and digital health and growth-stage, builds a shortlist of up to 300 matching investors for $49, one-time.
How these 316 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 121 | 38% |
| United Kingdom | 76 | 24% |
| Europe | 119 | 38% |
By US state
| US state | On this list | Share |
|---|---|---|
| California | 30 | 9% |
| New York | 21 | 7% |
| Massachusetts | 12 | 4% |
| Texas | 8 | 3% |
| Florida | 7 | 2% |
| Connecticut | 6 | 2% |
| Tennessee | 3 | 1% |
| Maryland | 3 | 1% |
| Washington | 3 | 1% |
| Pennsylvania | 3 | 1% |
By European country
| European country | On this list | Share |
|---|---|---|
| France | 42 | 13% |
| Netherlands | 15 | 5% |
| Germany | 13 | 4% |
| Italy | 8 | 3% |
| Sweden | 8 | 3% |
| Portugal | 5 | 2% |
| Spain | 5 | 2% |
| Austria | 5 | 2% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 211 | 67% |
| Fund manager | 37 | 12% |
| Government or university fund | 19 | 6% |
| Corporate VC | 15 | 5% |
| Angel network | 10 | 3% |
| SEIS/EIS fund | 7 | 2% |
Method and limits
- Source
- 121 of the 316 rows carry an SEC filing (Form D or Form ADV). All 316 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at growth-stage.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 316 rows: stage 316, sector 316, fund size 196, website 316. In the paid file: named decision-makers on 282 rows, firm email on 173, LinkedIn page on 210, check size on 92.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many growth-stage healthtech investors are there?
We list 316 as of November 2026. 133 of the 316 have a fund filing or a dated deal in the last 12 months.
Which growth-stage healthtech investors raised a new fund in the last 12 months?
45 of the 316 have a fund filing dated in the last 12 months. The most recent on this list are Audere (Oct 2026), IVP: Venture capital for the Exceptional (Oct 2026) and K5 Global (Oct 2026).
What is the typical fund size of growth-stage healthtech investors?
The median fund size on file for this list is $106M, across the 79 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 237 do not disclose a size there.
How do I contact growth-stage healthtech investors?
The paid file holds 1,525 named decision-makers across 282 of these 316 and a firm email for 173. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on growth-stage healthtech investors come from?
121 of the 316 rows have an SEC filing on file (Form D or Form ADV) and 195 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Narrower lists
Related lists
Seed healthtech investors (800)Pre-seed healthtech investors (408)Series A healthtech investors (401)Growth-stage SaaS investors (344)Growth-stage AI investors (295)Growth-stage fintech investors (214)Growth-stage deep tech investors (191)Growth-stage climate tech investors (189)Series B healthtech investors (160)Growth-stage consumer investors (124)Growth-stage B2B investors (119)Growth-stage biotech investors (109)Growth-stage medtech investors (107)Growth-stage energy investors (102)Growth-stage cybersecurity investors (92)Growth-stage industrial tech investors (81)Growth-stage food and beverage investors (67)Growth-stage mobility investors (55)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health and growth-stage. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.